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Abstract— Lithium is the main drug for the treatment of
mood disorders. Due to its narrow therapeutic window, Ther-
apeutic Drug Monitoring (TDM) is a norm during therapy
in order to avoid adverse effects. Consequently, patients are
obliged to frequent check-ups in hospitals to determine their
serum concentration and optimize accordingly the drug dose.
Wearable sensors have attracted a growing interest in the
research community in recent years owing to their promising
impact in personalized healthcare. In particular, sweat diagnosis
has seen an enormous expansion and is currently entering the
market thanks to the large availability and simple collection of
this fluid.
In this paper a novel approach for non-invasive decentral-
ized monitoring of lithium drug concentration through sweat
analysis is proposed for the first time. An all-solid-state Ion-
Selective Electrode (ISE) with a nanostructured Solid-Contact
(SC) is used to detect lithium ions in sweat. The sensor
offers near-Nernstian behaviour (57.6± 2.1 mV/decade) in
the concentration range of interest. In addition, it shows fast
response (15-30 s), good reversibility and small potential drift
over time. A wide pH stability window (pH 4-12) is also proved.
Index terms— bipolar disorder; sweat diagnosis; lithium
drug; drug monitoring; personalized healthcare; wearable elec-
trochemical sensors
I. INTRODUCTION
Lithium salts represent the oldest yet effective drugs to
control maniac episodes and reduce the risk of suicide of
psychiatric patients suffering from Bipolar Disorder (BD)
[1]. BD affects every year 60 million people worldwide
(WHO). In U.S. 2.6% of the adult population suffers from
this serious disease (National Institute of Mental Health).
BD is a potentially mortal brain disorder, which cannot be
cured, but only kept under control with specific drugs. People
with BD experience episodes of maniac and depressed mood,
separated by periods of normal mood. Maniac events can
induce unusually intense emotion, insomnia or hypersomnia,
aboulia, excessive weight changes and suicidal thoughts [2],
[3]. The risk of suicide is as high as 30% [4]. Therefore, after
diagnosis, there is an urgent need of stabilization therapy
with lithium compounds [5].
The main drawback related to lithium drug is its narrow
therapeutic window (0.5-1.5 mM) [6]. Poisoning can occur
if the serum concentration overcomes the maximum safe
concentration (1.5 mM). This can have severe consequences
on patients’ health, including ataxia, myoclonic twitching,
rowsiness, and chronic toxicity that can lead to irreversible
damages to liver, kidneys and brain [7]. It can eventually
Fig. 1. The concept of Therapeutic Drug Monitoring (TDM) of lithium in
sweat.
cause death. Individual variability, dietary variations and
interaction with other medicines also have a strong effect
on the determination of the optimum dose [7].
Consequently, Therapeutic Drug Monitoring (TDM) is
essential to determine the right therapy for each patient [8].
This is typically done at the beginning of the treatment
or after any change in the dose by monitoring lithium
concentration in serum at least every week (standardized
12h or 24h Li+ serum concentration). Only in absence of
any complications it is possible to decrease the check-ups
frequency. On the contrary, if some abnormalities are found,
the time interval between two subsequent analyses should be
increased accordingly. During maintenance serum tests are in
general performed every three months [1].
Lithium quantification in clinical laboratories is gener-
ally determined by complex and expensive techniques that
need to be performed by qualified staff. The most common
methods are atomic absorption spectrometry, flame emission
photometry or conventional Ion-Selective Electrodes (ISEs)
[9], but also photometry [10], [11] and colorimetry [6]
techniques have been investigated. In this regards, electro-
chemical sensors based on all-solid-state ISEs represent a
promising alternative thanks to their low cost and simplicity
of measurements. These advantages make them an ideal can-
didate for the realization of light portable devices that would
allow the remote monitoring of lithium serum concentration.
It is evident that a point-of-care system for TDM would avoid
frequent check-ups in hospitals, thus significantly improving
the life quality of the patients. However, only a few examples
have been reported in literature so far. A paper-based portable
ISE with carbon nanotubes as SC has been demonstrated to
measure lithium in serum [12]. A miniaturized Li+ ISE with
improved selectivity has been developed by using a graphite
composite for transduction [13]. These devices certainly offer
new interesting insights, however some major drawbacks still
need to be overcome. These include laborious fabrication,
toxicity, biocompatibility and reproducibility.
Lithium drug is absorbed in the gastrointestinal tract and
then distributed to extracellular fluids and tissues [14]. It
is then eliminated through kidneys, sweat and saliva. It
has been demonstrated by chromatographic measurements
that there is a correlation between the amount of lithium
extracted in sweat and the one present in serum [15]–[17]. In
particular, the concentration in sweat is about 3 times higher
the one in blood. The development of a portable device
to measure lithium concentration in sweat could be really
helpful to remove the need of frequent medical visits for
personalized therapy. Sweat offers several advantages over
serum: it is readily accessible without the need of syringes
and of invasive treatments, it is highly abundant and can be
even reproduced artificially following specific standards. A
scheme of the proposed TDM of lithium in sweat is given
in Figure 1. This is based on the use of a wearable patch for
direct perspiration analysis.
Wearable sensors have received a great interest in recent
years as a non-invasive method for health monitoring in
different biofluids, including sweat, tears and saliva [18]–
[20]. A lot of research is currently focusing on the first one as
a potential candidate to substitute blood analysis because of
the several advantages discussed earlier. Both ions and other
metabolites have been used as sweat biomarkers for different
purposes. Electrochemistry is the most investigated sensing
method because of good sensitivity, small sample volume,
low cost, simple design, easy integration into microfabrica-
tion processes for large-scale production and straightforward
signal interpretation. The most prominent examples are the
fully integrated sweat band described in Nature [21] and the
RFID sensor patch for sodium monitoring that appeared in
IEEE Spectrum [22].
In this paper we demonstrate for the first time the possi-
bility to monitor lithium concentration through perspiration
analysis (Fig. 1). The sensor is based on previously devel-
oped nanostructured Solid-Contacts (SCs) [23], [24]. We are
able to measure lithium concentration in sweat, with near-
Nernstian response (57.6 ± 2.1 mV/decade) in the range of
interest. Good reversibility, small drift and wide pH stability
(pH 4-12) have also been proved. These results open up new
interesting perspectives towards a non-invasive decentralized
management of lithium drug therapies.
II. EXPERIMENTAL METHODS
A. Material
NaCl and NH4Cl were purchased from Applichem GmbH
(Germany). DL-Lactic acid, pyruvic acid and urea were pur-
chased from Acros (United States). Uric acid was purchased
from Alfa Aesar (United States). All other chemicals were
purchased from Merck (Germany).
B. ISM fabrication
After the electrochemical cleaning of the electrodes [23],
platinum nanostructures were electrodeposited on platinum
electrodes with an active area of 12.56 mm2 (Dropsens,
Spain) using an Autolab Potentiostat controlled by Nova
Software (Metrohm, Switzerland), as described elsewhere
[23]. 1 wt% Li Ionophore VI, 0.7 wt%, Potassium tetrakis(4-
chlorophenyl)borate, 28.00 wt% Poly(vinyl chloride) high
molecular weight, and 70.3 wt% 2-Nitrophenyl octyl ether
for 100 mg of mixture were dissolved in 1 ml of Tethraydro-
furan (THF). A volume of 10 µl of membrane cocktail was
drop-casted on the nanostructured electrodes. These were
then kept for 24 hours at dark to allow proper drying. A
conditioning step of 24 hours in a 0.003 M LiCl solution
was performed prior to each measurement.
C. Artificial Perspiration
Artificial sweat was prepared according to the composition
reported in Table I [25].
TABLE I





Acetic acid 0.08 M
DL-Lactic acid 0.20 M
Ascorbic acid 10 µM
Glucose 0.17 mM
Uric acid 59 µM
Pyruvic acid 0.18 mM
Glutamic acid 0.37 mM
Urea 10 mM
D. Electrochemical characterization
All potentiometric measurements were performed using an
Autolab potentiostat (Metrohm, Switzerland) controlled by a
Nova 1.11 software in a two-electrodes cell setup. A double
junction Sension+ 5044 Reference Electrode (Hach, United
States) for use with ISEs was employed in all measurements.
III. EXPERIMENTAL RESULTS AND DISCUSSION
In our recent work we develop and compare different
nanostructured SCs for all-solid-state ISEs with a one-step
electrodeposition of noble metals [24]. This technology of-
fers several advantages over carbon-based SCs and conduc-
tive polymers, including fast deposition, biocompatibility and
non-toxicity. We proved that these systems have enhanced
analytical capabilities in aqueous solutions. In this paper, for
the first time we use these sensors to monitor lithium levels
in sweat. The great performance of the fabricated devices in
Fig. 2. Calibration curve of a Li+ SC-ISE in sweat. The inset shows the
corresponding time trace.
TABLE II
ANALYTICAL PARAMETERS IN SWEAT OF A Li+ ISES BASED ON
NANOSTRUCTURED SCS.
This work Literature
sensitivity 57.6±2.1 58.7±0.8 [24]
[mV/decade] (aqueous solution)
LOD (13.5± 2.1)× 10−4 5× 10−6 [13]
[M] (aqueous solution)
Response time 15-30 15-30 [24]
[s] (aqueous solution)
pH stability 4-12 4-12 [12]
(serum)
this biological fluid is demonstrated, proving the feasibility
of lithium drug monitoring through perspiration analysis.
An example of a typical calibration curve obtained in a
perspiration solution is given in Figure 2. The corresponding
time trace is given in the small inset. It is possible to observe
that very stable and smooth time responses were obtained,
with sharp steps after every subsequent lithium addition.
A summary of all analytical parameters and statistics is
given in table II in comparison with the best values reported
in literature. It is possible to notice that the slope of the
calibration curve is 57.6±2.1 mV/decade, which demonstrate
the near-Nernstian behaviour of the sensor. The higher
standard deviation with respect to [24] can be explained
by considering that in the present paper the calibration is
performed in sweat, in the presence of more interactions in
solution. The Limit Of Detection (LOD) is computed as the
intersection of the linear portions of the calibration curve,
as prescribed by IUPAC definitions [26]. Although higher
with respect to the ones reported in literature for aqueous
solutions, this value is still in the concentration window of
interest for lithium drug in sweat, that is around 3 times the
corresponding amount in serum. In addition, the response
time in sweat does not increase with respect to the one
obtained in simple LiCl aqueous solutions.
The strongest interference in Li+ measurements is typi-
cally due to sodium ions because of the similar dimensions
of this element. The high selectivity of the nanostructured
Fig. 3. Reversed calibration in the range 10−3−10−1 M of a Li+ SC-ISE
in sweat.
Fig. 4. Sensor stability over time when exposed to sweat with 0.01 M LiCl.
The two curves correspond to the responses of two distinct electrodes.
sensors used in this work was already demonstrated in aque-
ous solution in [24] towards all most important ions (Na+,
K+, Ca2+, Mg2+, NH4+) using both the Separate Solution
Method (SSM) and the Fixed Interference Method (FIM).
The quasi-Nernstian calibration obtained in the present study
in the presence of a large amount of sodium ions and of
several other compounds in sweat confirms our previous
findings.
An important element to allow proper measurements in
sweat is sensor stability over sweat pH, since the acidity
of perspiration is subjected to personal and environmental
variability. The typical sweat pH value ranges from 4.5 to
7 [27]. The stability window versus pH of the sensor was
measured by exposing the sensor to sweat at a constant
lithium concentration of 10−2 M, but with different acidity.
The sensor response is stable in the window of pH 4-
12, thus proving the suitability of the fabricated ISE for
sweat analysis. This property is extremely important to allow
simple data interpretation and offers an important advantage
over other pH-sensitive techniques.
The potential shown by the sensor when exposed to a
constant concentration of lithium ions in sweat was compared
to the value obtained by the calibration curve to analyze the
predictive capability of the sensor. A percentage difference
smaller than 4% was always found, thus corroborating the
good stability of the sensor.
The dynamic response of the sensor in the perspiration
solution was investigated by performing a reversed calibra-
tion in the range 10−3 − 10−1 M. The resulting curve is
reported in Figure 3. It is possible to see that the fabricated
all-solid-state ISE offer an exceptional potential stability
and reversibility in sweat. Moreover, the small potential
drift is evident also from the potential measurements over
a prolonged period of time when the sensors is placed in
perspiration solution with a constant lithium concentration
(Fig. 4). A concentration of 0.01 M LiCl in sweat was used
for this experiment.
Based on these results, the integration of this sensor in
a wearable smart patch for sweat analysis will certainly
offer a new promising and non-invasive approach for home-
monitoring of lithium drug therapy directly on the skin.
IV. CONCLUSION
In this paper, the novel idea of monitoring lithium drug
concentration by non-invasive means through sweat anal-
ysis directly on the skin is proposed. The feasibility of
lithium ions detection in perspiration solution is proved.
A quasi-Nernstian (57.6± 2.1 mV/decade) calibration curve
is obtained in the concentration range of interest for this
application. Furthermore, we demonstrate that the fabricated
sensors offer good reversibility and pH stability (pH 4-12)
in sweat. A very short response time (15-30 s) and small
potential drift are also achieved. The integration of these
sensors in a wearable smart patch will certainly represent
an important step towards a better personalized healthcare
and a new non-invasive way for decentralized monitoring of
lithium drug therapy for people suffering from BD.
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